cycloheximide has been researched along with Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greene, LA; Jackson-Lewis, V; Jin, ZH; Malagelada, C; Przedborski, S | 1 |
| Arawaka, S; Fukushima, S; Hara, S; Kato, T; Koyama, S; Machiya, Y; Sakamoto, M; Sato, H | 1 |
| Anar, B; Bonifati, V; Bronner, IF; Cannella, M; Heutink, P; Hoogeveen, A; Macedo, MG; Rizzu, P; Squitieri, F | 1 |
| Beyer, K; Görner, K; Haass, C; Holtorf, E; Kahle, PJ; Nuscher, B; Odoy, S; Regula, JT; Yamamoto, A | 1 |
| Di Monte, DA; Ethell, DW; Fei, Q; McCormack, AL | 1 |
| Agid, Y; Anglade, P; Michel, PP; Ruberg, M; Vyas, S | 1 |
| Barzilai, A; Melamed, E; Offen, D; Shirvan, A; Zilkha-Falb, R; Ziv, I | 1 |
| Dostert, P; Hashizume, Y; Kasamatsu, T; Kohda, K; Maruyama, W; Naoi, M; Takahashi, T | 1 |
| Jimenez Del Rio, M; Velez-Pardo, C | 1 |
9 other study(ies) available for cycloheximide and Parkinson Disease
| Article | Year |
|---|---|
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cell Death; Cycloheximide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Serine; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Transcription Factors; Transfection; Tyrosine 3-Monooxygenase | 2010 |
Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner.
Topics: Acetylcysteine; alpha-Synuclein; Animals; Cell Line, Tumor; Cerebral Cortex; Cycloheximide; Cysteine Proteinase Inhibitors; Humans; Leupeptins; Lewy Bodies; Neurons; Okadaic Acid; Parkinson Disease; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Phosphatase 1; Protein Phosphatase 2; Protein Synthesis Inhibitors; Rabbits; Ubiquitin | 2010 |
The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes.
Topics: Animals; Chlorocebus aethiops; COS Cells; Cycloheximide; Dimerization; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Lymphocytes; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Oncogene Proteins; Parkinson Disease; Protein Deglycase DJ-1; Protein Denaturation; Protein Inhibitors of Activated STAT; Protein Synthesis Inhibitors; Synucleins | 2003 |
Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1.
Topics: Cell Line; Circular Dichroism; Cycloheximide; Cysteine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Escherichia coli; Gene Deletion; Humans; Intracellular Signaling Peptides and Proteins; Leupeptins; Mass Spectrometry; Multienzyme Complexes; Mutagenesis, Site-Directed; Mutation; Neurons; Oncogene Proteins; Parkinson Disease; Point Mutation; Proteasome Endopeptidase Complex; Protein Conformation; Protein Deglycase DJ-1; Protein Folding; Protein Structure, Secondary; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Temperature; Time Factors | 2004 |
Paraquat neurotoxicity is mediated by a Bak-dependent mechanism.
Topics: Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Caspase 3; Cell Survival; Cycloheximide; Gene Expression Regulation; Herbicides; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Paraquat; Parkinson Disease; Poly(ADP-ribose) Polymerases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2 | 2008 |
Morphological and molecular characterization of the response of differentiated PC12 cells to calcium stress.
Topics: Animals; Apoptosis; Calcimycin; Calcium; Cell Differentiation; Cell Survival; Cycloheximide; DNA; DNA Damage; Dopamine; Dose-Response Relationship, Drug; Humans; Microscopy, Electron; Models, Neurological; Neurites; Neurons; Parkinson Disease; PC12 Cells; Tyrosine 3-Monooxygenase | 1994 |
Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?
Topics: Animals; Antioxidants; Antiparkinson Agents; Apoptosis; Cell Count; Cell Survival; Cells, Cultured; Chick Embryo; Corpus Striatum; Cycloheximide; Dactinomycin; Flow Cytometry; Ganglia, Sympathetic; Humans; Levodopa; Microscopy, Fluorescence; Nerve Degeneration; Neurons; Parkinson Disease; Substantia Nigra | 1997 |
An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Apoptosis; Carcinogens; Catalase; Cycloheximide; DNA Damage; Dopamine; Free Radicals; Humans; Microscopy, Fluorescence; Neuroblastoma; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction; Parkinson Disease; Protein Synthesis Inhibitors; Salsoline Alkaloids; Selegiline; Semicarbazides; Stereoisomerism; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1997 |
17 beta-estradiol protects lymphocytes against dopamine and iron-induced apoptosis by a genomic-independent mechanism. Implication in Parkinson's disease.
Topics: Adult; Apoptosis; Cycloheximide; Dactinomycin; DNA Fragmentation; Dopamine; Electrophoresis, Agar Gel; Estradiol; Genomics; Humans; Hydrogen Peroxide; Iron; Lymphocytes; Male; Parkinson Disease; Predictive Value of Tests; Protein Synthesis Inhibitors; Receptors, Estrogen | 2000 |